Who
John Bradley Holcomb
Director
Company insider
Files Form 4 as: Director, MiNK Therapeutics.
In numbers
- Trades disclosed
- 9
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 23 Sep 2025
- Last trade
- 1 Sep 2026
- Last filed
- 2 Sep 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Sep 2026filed 2 Sep 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $14K1,233 at $10.95 | filing |
| 1 Sep 2026filed 2 Sep 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $14K1,233 at $10.95 | filing |
| 1 Jun 2026filed 2 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $14K1,091 at $12.38 | filing |
| 1 Jun 2026filed 2 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $14K1,091 at $12.38 | filing |
| 2 Mar 2026filed 2 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $14K1,239 at $10.90 | filing |
| 2 Mar 2026filed 2 Jun 2026 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $14K1,239 at $10.90 | filing |
| 1 Dec 2025filed 3 Dec 2025 | INKT MiNK TherapeuticsBiotechnology | SEC FORM 4 Code A | $13K1,128 at $11.09 | filing |
| 23 Sep 2025filed 30 Apr 2026 | INKT MiNK Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,174 at $0.00 | filing |
| 23 Sep 2025filed 30 Apr 2026 | INKT MiNK Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —4,174 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.